-
Most Popular
![Healthcare Stocks Icon](https://investorplace.com/wp-content/uploads/2022/12/healthcare-150x150.png)
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
![The words "recession proof" written on a pink sticky note. bulletproof stocks](https://investorplace.com/wp-content/uploads/2023/07/shutterstock_2170602547-150x150.jpg)
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
![Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks](https://investorplace.com/wp-content/uploads/2024/06/dividend-stocks1600-5-150x150.png)
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
![medicine research, pharmaceutical background, LJPC stock](https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-150x150.png)
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
Why Is Invo Bioscience (INVO) Stock Up 2,000% Today?
Invo Bioscience (INVO) stock appears to be rocketing higher on Friday but it's actually undergoing a reverse stock split.
Why Is National Vision (EYE) Stock Down 12% Today?
National Vision (EYE) stock is dropping on Thursday as a deal it has with Walmart (WMT) is going to come to an end in 2024.
Why Is Lipocine (LPCN) Stock Up 32% Today?
Lipocine (LPCN) stock is rising higher on Thursday after the company released positive results from a Phase 2 clinical trial.
Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.
Why Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?
Bellerophon Therapeutics (BLPH) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice.
Why Is Humanigen (HGEN) Stock Down 72% Today?
Humanigen (HGEN) stock is falling hard on Tuesday after the company warned investors it can't keep listing requirements.
Why Is PaxMedica (PXMD) Stock Up Today?
Although PaxMedica delivered encouraging top-line results for a Phase 3 study, PXMD stock remains a risky investment.
Why Is Kodiak Sciences (KOD) Stock Down 58% Today?
Kodiak Sciences (KOD) stock is falling hard on Monday after the company released results from a series of Phase 3 clinical trials.
Why Is Kiora Pharmaceuticals (KPRX) Stock Down 7% Today?
Kiora Pharmaceuticals (KPRX) stock is dropping on Friday after the clinical-stage pharmaceutical company received a delisting notice.